Novartis | NVS - Market Capitalization

Stock Price
149.86
Daily Change
-1.21 -0.80%
Monthly
8.70%
Yearly
41.99%
Q1 Forecast
145.07

Novartis reported $308.83B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 409.03B 81.15B Sep/2025
Amgen USD 185.28B 33.35B Feb/2026
AstraZeneca USD 233.07B 17.56B Sep/2025
Bausch Health Companies USD 2.38B 979.68M Sep/2025
Biogen USD 20.54B 2.13B Sep/2025
Bristol-Myers Squibb USD 91.8B 2.4B Sep/2025
Canopy Growth CAD 136.67M 644.68M Feb/2026
Corcept Therapeutics USD 8.76B 977M Sep/2025
Drreddys Laboratories INR 2.28B 9.41B Feb/2026
Eli Lilly USD 722.15B 16.64B Sep/2025
Gilead Sciences USD 137.73B 184M Sep/2025
GlaxoSmithKline GBP 64.04B 7.8B Sep/2025
Glaxosmithkline GBP 106.96B 20.08B Feb/2026
J&J USD 500.24B 67.44B Dec/2025
Merck USD 294.09B 84.45B Feb/2026
Novartis USD 265.66B 9.48B Sep/2025
Novartis USD 303.91B 57.84B Feb/2026
Pacira USD 1.16B 51M Sep/2025
Perrigo USD 2.95B 698M Sep/2025
Pfizer USD 145.87B 10.78B Feb/2026
Prestige Brands USD 3.07B 860M Sep/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
Sanofi EUR 118.94B 1.6B Feb/2026
Supernus Pharmaceuticals USD 3B 1.24B Sep/2025
Zoetis USD 64.85B 4.58B Sep/2025